NCT02179827

Brief Summary

The aim of this study is to assess the responsiveness of the standard minimally invasive hemodynamic monitors used in the operating room to known changes in the intravascular volume status that occur during blood removal and volume replacement with three different standard fluids used during ANH.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 2, 2014

Completed
8.3 years until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

1 year

First QC Date

March 11, 2014

Last Update Submit

April 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in cardiac output

    Metrics: Cardiac output stroke volume Stroke volume: variation

    Baseline (Supine) Volume Replaced (S/P ANH)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective procedures requiring normovolemic hemodilution

You may qualify if:

  • Those surgical procedures where ANH is included in the surgical plan and consent is obtained

You may not qualify if:

  • Severe or symptomatic COPD, emphysema, renal, hepatic or coronary artery disease as defined by the American College of Cardiology (Cannon et al., 2001).
  • Esophageal pathology (diverticulum, hiatal hernia, esophageal cancer, esophageal surgery), which introduces risks associated with the placement of the esophageal Doppler.
  • Ascites.
  • BMI \>35
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Health System

Sacramento, California, 95832, United States

Location
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2014

First Posted

July 2, 2014

Study Start

November 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2024

Last Updated

April 27, 2022

Record last verified: 2022-04

Locations